NEW

UVDI-360 Room Sanitizer Inactivates SARS-CoV-2 at 12 Feet Distance in 5 Minutes

UltraViolet Devices Inc. (UVDI) has announced that its UVDI-360 Room Sanitizer achieved greater than 99.99%, or 4log10, inactivation of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in 5 minutes at a distance of 12 feet (3.65 meters).

oneSOURCE Creates Free Resource Page with Up-to-Date COVID-19 Vaccine Information

Today, oneSOURCE, an RLDatix company and leading healthcare management solution, announced a new COVID-19 vaccine resource page to assist healthcare professionals during the initial administration phases of the vaccine.

STERIS to Acquire Cantel Medical

STERIS plc and Cantel Medical Corp. announced that STERIS has signed a definitive agreement to acquire Cantel, through a U.S. subsidiary. Cantel is a global provider of infection prevention products and services primarily to endoscopy and dental Customers.

NEC Releases ‘WISE VISION Endoscopy’ in Europe and Japan

NEC Corporation has announced the development of “WISE VISION Endoscopy,” an AI diagnosis-support medical device software for colonoscopies, which is being released in Japan and is expected to soon be available in Europe.

NuVasive LessRay Platform Wins ‘Best New Imaging Technology Solution’ Award

NuVasive Inc. announced its LessRay radiation reduction and workflow enhancement platform won the “Best New Imaging Technology Solution” award in the 2020 MedTech Breakthrough Awards.

The MedTech Breakthrough Awards recognize innovative companies, technologies and products from around the world, and this award is the fourth honor the LessRay platform has achieved from prestigious organizations and publications within the health care industry. The platform won the 2019 Spine Technology Award and was a gold winner in both the Advanced Surgical Instruments category at the 2019 Edison Awards and the Radiological, Imaging and Electromechanical Devices category at the 2019 Medical Design Excellence Awards.

“NuVasive is honored to receive the best new imaging technology solution award for LessRay, and be featured alongside other outstanding innovations from medical and health care companies around the world,” said Matt Link, president of NuVasive. “This award adds to the growing market recognition of LessRay and reinforces its clinical benefits of reducing radiation exposure in the operating room, making it a safer environment for patients, surgeons and their staff.”

The LessRay platform is composed of a propriety software algorithm and hardware components that help address overexposure to radiation in hospital operating rooms, particularly in the case of minimally invasive spine surgery. Studies show that spine and orthopedic surgeons can receive their lifetime radiation limit within the first 10 years of their career and LessRay has the ability to reduce radiation emissions by up to 80 percent compared to standard fluoroscopy. LessRay’s proprietary image enhancement technology improves low-dose fluoroscopy images to have similar diagnostic capabilities as conventional full-dose fluoroscopy images, thereby reducing radiation emission and exposure in the operating room. Additionally, LessRay’s other features help reduce the number of fluoroscopic shots needed and can ultimately decrease overall radiation exposure further. These features include:

  • C-arm tracking: Simplifies localization and helps navigate to the targeted anatomy quickly and accurately without unnecessary scouting images.
  • Image stitching: Minimizes surgical workflow interruption by quickly stitching together fluoroscopic images of any spine segment.
  • Angle finder: Minimizes OR steps required to obtain crisp endplate shots with fewer fluoroscopic images than traditional C-arm scouting.
  • Alternate view: Improves visualization by making metal instruments invisible or semi-transparent to reduce obstruction of the anatomy.
  • Integrated Global Alignment (iGA): Allows for assessment of spinal alignment directly on LessRay’s enhanced stitched images.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X